4.7 Article

Total synthesis of TRADD death domain with arginine N-GlcNAcylation by hydrazide-based native chemical ligation

Journal

CHINESE CHEMICAL LETTERS
Volume 31, Issue 1, Pages 107-110

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2019.05.010

Keywords

TRADD death domain; Posttranslational modification; Protein chemical synthesis; Solid-phase peptide synthesis; Native chemical ligation; Peptide hydrazide

Funding

  1. National Natural Science Foundation of China [91849129, 21807112]
  2. PLA Youth Medical Science and Technology Youth Development Program [16QNP086]
  3. Foundation of Second Military Medical University [2016JS11]

Ask authors/readers for more resources

TNFR1-associated death domain protein (TRADD) with arginine N-GlcNAcylation is a novel and structurally unique posttranslational modification (PTM) glycoprotein that blocks the formation of death-inducing signaling complex (DISC), orchestrating host nuclear factor KB (NF-kappa B) signaling in entero-pathogenic Escherichia coli (EPEC)-infected cells. This particular glycosylated modification plays an extremely vital role for the effective colonization and pathogenesis of pathogens in the gut. Herein we describe the total synthesis of TRADD death domain (residues 195-312) with arginine235 N-GlcNAcylation (Arg-GlcNAc TRADD (195-312)). Two longish peptidyl fragments of the wild-type primary sequence were obtained by robust, microwave-assisted, highly efficient, solid-phase peptide synthesis (SPPS), the N-GlcNAcylated sector was built by total synthesis and attached specifically to resin bound peptide with an unprotected ornithine residue via silver-promoted on-resin guanidinylation, ArgGlcNAc TRADD (195-312) was constructed by hydrazide-based native chemical ligation (NCL). The facile synthetic strategy is expected to be generally applicable for the rapid synthesis of other proteins with Arg-GlcNAc modification and to pave the way for the related chemically biological study. (C) 2019 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available